Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

teva_copy

Migraine drug bad news hits a weakened Teva

February 9, 2018 Medical Communications, Sales and Marketing CGRP, Teva, biotech, drugs, pharma, pharmaceutical

The cacophony of bad news that Teva has received in 2017 really needs no retelling, anyone following the story of …
News
peter_goldschmidt_web

Stada poaches Novartis exec for fifth CEO in two years

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Stada, appointment

Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and …
Appointment
bob_hugin1

Celgene Executive Chairman Bob Hugin retires

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Fresh from its acquisition of Juno Therapeutics, Celgene announced that its Executive Chairman Bob Hugin was to retire effective 5 …
Appointment
online_feature_image

New Year, new goals

February 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer Research UK, Chiesi, EMA, FDA, Genetic Alliance, pharma

With the New Year begun in earnest, Pharmafocus speaks to a range of players in pharma and the life sciences …
Feature
kenji

Astellas confirms Kenji Yasukawa as new President and CEO

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, appointment

Japanese pharmaceutical firm Astellas has announced that its Board of Directors has approved the selection of current Chief Strategy Officer …
Appointment
arcturus_joseph-e-payne

CEO gets the axe: Arcturus relieve Payne of position

February 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arcturus, biotech, drugs, pharma, pharmaceutical

Early in February, Arcturus Therapeutics revealed that it had let its CEO, Joseph Payne, go and had replaced him as …
Appointment
flu

NHS tells doctors to order stronger vaccine for next winter

February 7, 2018 Medical Communications, Research and Development NHS, biotech, drugs, flu season, pharma, pharmaceutical

England is not alone in being particularly hard hit this flu season, with Australia suffering its worst flu season in …
News
mark_walsh_allergan

Allergan successfully concludes CFO search

February 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

Allergan has been searching for a new Chief Financial Officer since Tessa Hilado, its current CFO, revealed that she would …
Appointment
450px-papilloma_virus_hpv

UK Government to offer HPV vaccine to men who have sex with men

February 6, 2018 Manufacturing and Production, Medical Communications, Research and Development England, HPV, UK, human papillomavirus, pharma, vaccination

The UK Government has confirmed a national vaccination programme that will provide access for men who have sex with men(MSM) …
News

Two former Greek PMs implicated in Novartis bribery case

February 6, 2018 Manufacturing and Production, Medical Communications Greece, Novartis, biotech, drugs, pharma, pharmaceutical

An ongoing investigated case into Novartis sales practices in Greece has so far implicated 10 current and former politicians. The …
News
ai_graphic

The future is now: The transformative power of AI

February 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …
Feature
shutterstock_158366573

UK GPs are “undervalued” with 40% looking to quit profession, study finds

February 5, 2018 Medical Communications, Sales and Marketing GPs, NHS, UK, health, pharma

Falling numbers of General Practitioners (GPs) in the UK are due to “concerns regarding professional risk in delivering care in …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Alzheimer's, Apotex, AstraZeneca, Brexit Health Alliance, CDC, Duchenne Muscular Dystrophy, EMA, Italy, Sanofi, amazon, brexit, santhera, top ten

It’s the first Friday of February, and it’s time for another recap of the top ten articles most popular with …
News

Array BioPharma demands $192m after AstraZeneca refuses to pay royalties

February 2, 2018 Medical Communications, Sales and Marketing Array Biopharma, AstraZeneca, lawsuit, selemetinib

Array BioPharma has launched a lawsuit against AstraZeneca over allegations the latter has refused to pay royalties it owes for …
News
allergan

Allergan’s Avycaz becomes first FDA-approved gram-negative antibiotic in over 15 years

February 2, 2018 Medical Communications, Sales and Marketing Allergan, Avycaz, FDA, pharma, pneumonia

Allergan has announced that the FDA has awarded approval to its fixed-dose combination antibacterial Avycaaz (ceftazidme and avibactam) for the …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026